To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene NUP160TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
313 supporting clones for gene NUP160 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
NM_015231.1   .a 1 to 5383 1 to 5383 exact RefSeq,   5383/5383
(100 %)
1 diff
(100.0 %id)
BC125227 PCR rescued clones .a 39 to 4581 1 to 4543 T351A tiling clone,   4543/4543
(100 %)
2 diff
(100.0 %id)
BC125228 PCR rescued clones .a 39 to 4581 1 to 4543 T351A     4543/4543
(100 %)
2 diff
(100.0 %id)
DB461429 testis .a 150 to 641 1 to 492       492/492
(100 %)
2 diff
(99.6 %id)
DA724837   .a 152 to 704 2 to 555   capped   554/554
(100 %)
2 diff
(99.7 %id)
DA489841 brain .a 160 to 724 2 to 566   capped   565/565
(100 %)
2 diff
(99.7 %id)
DR001567 fetal brain .a 161 to 909 1 to 749       749/749
(100 %)
6 diff
(99.2 %id)
DA461555 tongue, tumor tissue .a 162 to 718 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
BX502749 Liver .a 163 to 486 1 to 324       324/324
(100 %)
29 diff
(91.1 %id)
CR987781 T-Lymphocytes .a 167 to 1094 1 to 928       928/928
(100 %)
3 diff
(99.7 %id)
DB082173 testis .a 169 to 736 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DB448587 testis .a 170 to 589 1 to 419       419/419
(100 %)
18 diff
(95.8 %id)
DB442969 testis .a 171 to 588 1 to 418       418/418
(100 %)
5 diff
(98.9 %id)
AL832029 human skeletal muscle .a 172 to 5381 1 to 5208   available from DKFZ, AAA   5208/5209
(99 %)
12 diff
(99.8 %id)
BX500974 Liver .a 175 to 453 1 to 281       281/281
(100 %)
14 diff
(95.1 %id)
AK304308 trachea .a 176 to 4773 1 to 4598   tiling clone,   4598/4598
(100 %)
2 diff
(100.0 %id)
CR977476 T-Lymphocytes .a 176 to 1018 1 to 847       845/847
(99 %)
8 diff
(99.1 %id)
DA798700 brain .a 177 to 721 2 to 546   capped   545/545
(100 %)
1 diff
(99.9 %id)
DB232382 trachea .a 177 to 765 2 to 590   capped   589/589
(100 %)
1 diff
(99.9 %id)
DB062328 testis .a 180 to 714 2 to 537   capped   536/536
(100 %)
2 diff
(99.7 %id)
CN420735 embryonic stem cells, DMSO-treated H9 cellline .a 181 to 952 1 to 772       772/772
(100 %)
0 diff
(100 %id)
CX760383 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 181 to 950 1 to 767     Submitted on the opposite strand 767/768
(99 %)
4 diff
(99.5 %id)
DB727745 testis .a 183 to 833 1 to 644       644/712
(90 %)
24 diff
(96.7 %id)
BM475877 eye, retinoblastoma .a 191 to 1164 1 to 982       982/1020
(96 %)
28 diff
(97.3 %id)
CT001922 T-Lymphocytes .a 197 to 935 1 to 742       742/742
(100 %)
3 diff
(99.6 %id)
CD643035 Embryonic Stem cells .a 212 to 950 12 to 750       739/750
(98 %)
6 diff
(99.2 %id)
DW424196 Liver .a 442 to 714 17 to 289       273/289
(94 %)
6 diff
(98.0 %id)
BF344291 brain, glioblastoma with EGFR amplification .a 536 to 1391 1 to 860       860/867
(99 %)
19 diff
(97.9 %id)
DB090436 testis .a 644 to 1213 2 to 571   capped   570/570
(100 %)
1 diff
(99.9 %id)
DA505817 brain .a 655 to 1233 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
BE004509 breast_normal .a 672 to 1079 407 to 1     Submitted on the opposite strand 407/407
(100 %)
5 diff
(98.8 %id)
BU431094 lymph .a 719 to 1178 1 to 460       460/460
(100 %)
5 diff
(99.0 %id)
DW418719 Liver .a 726 to 1132 12 to 418       407/418
(97 %)
6 diff
(98.6 %id)
TI_154152909   .a 726 to 1311 80 to 664       585/585
(100 %)
8 diff
(98.7 %id)
W27454 eye, retina .a 735 to 1261 15 to 543       527/584
(90 %)
14 diff
(97.7 %id)
DA092944 cerebellum .a 772 to 1243 2 to 473   capped   472/472
(100 %)
0 diff
(100 %id)
AA368157 placenta .a 943 to 1255 312 to 1       312/312
(100 %)
2 diff
(99.4 %id)
DA099998 cerebellum .a 1010 to 1461 2 to 453   capped   452/452
(100 %)
2 diff
(99.6 %id)
BM559192 eye, retinoblastoma .a 1020 to 1868 1 to 855       855/1034
(82 %)
17 diff
(98.4 %id)
BG995429 head_neck .a 1028 to 1352 1 to 324       324/325
(99 %)
12 diff
(96.4 %id)
DW459204 Liver .a 1060 to 1199 10 to 149       140/149
(93 %)
6 diff
(96.0 %id)
AW503584 lymph .a 1198 to 1620 1 to 423       423/423
(100 %)
4 diff
(99.1 %id)
TI_154159522   .a 1204 to 1669 82 to 547       466/467
(99 %)
2 diff
(99.6 %id)
DB090505 testis .a 1230 to 1796 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DA720368   .a 1240 to 1697 2 to 459   capped   458/484
(94 %)
1 diff
(99.8 %id)
DA738864   .a 1355 to 1899 2 to 546   capped   545/545
(100 %)
1 diff
(99.9 %id)
DB087618 testis .a 1361 to 1910 2 to 551   capped   550/550
(100 %)
2 diff
(99.7 %id)
BF091763 testis_normal .a 1368 to 1743 401 to 24       378/401
(94 %)
2 diff
(99.6 %id)
BG980431 colon_normal .a 1370 to 1568 205 to 10       196/206
(95 %)
1 diff
(99.6 %id)
BG393750 embryonal carcinoma, cell line, testis .a 1375 to 2058 1 to 678       678/678
(100 %)
18 diff
(97.4 %id)
CD642956 Embryonic Stem cells .a 1386 to 2120 12 to 746       735/747
(98 %)
13 diff
(98.3 %id)
DN602297 human embryonic stem cells .a 1406 to 2275 1 to 870       870/870
(100 %)
2 diff
(99.8 %id)
CN344617 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1410 to 1924 1 to 515       515/515
(100 %)
1 diff
(99.9 %id)
AW501094 lymph .a 1473 to 1941 1 to 469       469/469
(100 %)
2 diff
(99.6 %id)
CF121940 lymph .a 1473 to 2178 1 to 705       705/705
(100 %)
3 diff
(99.6 %id)
TI_154155684   .a 1477 to 1960 80 to 563       484/485
(99 %)
2 diff
(99.6 %id)
TI_154181315   .a 1477 to 2306 70 to 898       829/831
(99 %)
8 diff
(99.1 %id)
CX784393 human embryonic stem cells .a 1486 to 2292 1 to 807       807/807
(100 %)
1 diff
(99.9 %id)
DB074479 testis .a 1487 to 2031 2 to 546   capped   545/545
(100 %)
2 diff
(99.7 %id)
DA797625 brain .a 1496 to 2052 2 to 558   capped   557/557
(100 %)
1 diff
(99.9 %id)
DA440901 tongue, tumor tissue .a 1552 to 2091 2 to 541   capped   540/540
(100 %)
1 diff
(99.9 %id)
DA458891 tongue, tumor tissue .a 1636 to 2181 2 to 547   capped   546/546
(100 %)
2 diff
(99.7 %id)
DA805775 brain .a 1761 to 2292 2 to 534   capped   533/533
(100 %)
2 diff
(99.7 %id)
ES315913 melanoma cell line .a 1813 to 2262 504 to 55     Submitted on the opposite strand 450/504
(89 %)
5 diff
(99.1 %id)
AU127538   .a 1962 to 2691 2 to 736   capped   735/769
(95 %)
19 diff
(97.6 %id)
DA994780 synovial membrane tissue from rheumatioidarthritis .a 2044 to 2599 2 to 557   capped   556/556
(100 %)
1 diff
(99.9 %id)
AU130557   .a 2046 to 2871 2 to 827   capped   826/835
(98 %)
2 diff
(99.8 %id)
AU128997   .a 2120 to 2747 2 to 632   capped   631/635
(99 %)
13 diff
(98.0 %id)
BF375736 stomach .a 2125 to 2648 28 to 552       525/552
(95 %)
18 diff
(96.8 %id)
BI048093 stomach .a 2125 to 2545 9 to 429       421/429
(98 %)
6 diff
(98.7 %id)
DA123385 cerebellum .a 2129 to 2610 2 to 484   capped   483/483
(100 %)
2 diff
(99.6 %id)
BI047922 stomach .a 2131 to 2615 16 to 498       483/501
(96 %)
13 diff
(97.5 %id)
AU131259   .a 2133 to 2978 12 to 849   capped   838/888
(94 %)
10 diff
(98.9 %id)
BI048304 stomach .a 2140 to 2492 6 to 360       356/399
(89 %)
18 diff
(95.5 %id)
BI048288 stomach .a 2144 to 2441 7 to 305       299/309
(96 %)
12 diff
(96.2 %id)
BG897028 cartilage .a 2151 to 2485 86 to 419       334/351
(95 %)
5 diff
(98.6 %id)
BE825406 lung_normal .a 2176 to 2328 179 to 30       150/182
(82 %)
0 diff
(100 %id)
AW389586 stomach .a 2190 to 2375 1 to 186       186/186
(100 %)
5 diff
(97.4 %id)
DA456287 tongue, tumor tissue .a 2230 to 2794 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
CD707026 normal nasopharynx .a 2234 to 2770 24 to 561       538/561
(95 %)
8 diff
(98.6 %id)
DB132699 thymus .a 2317 to 2859 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
DA498281 brain .a 2327 to 2882 12 to 568   capped   557/567
(98 %)
7 diff
(98.8 %id)
DA754925   .a 2327 to 2855 11 to 539   capped   529/538
(98 %)
6 diff
(98.9 %id)
DB072737 testis .a 2327 to 2840 12 to 529   capped   518/528
(98 %)
8 diff
(98.5 %id)
DA555932   .a 2348 to 2921 2 to 577   capped   576/576
(100 %)
2 diff
(99.7 %id)
CN344615 embryonic stem cells, cell lines H1, H7, andH9 .a 2364 to 3048 1 to 686       686/686
(100 %)
2 diff
(99.8 %id)
DA473147   .a 2374 to 2925 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
BU902111 leiomyosarcoma, uterus .a 2473 to 3416 1 to 951       951/1140
(83 %)
12 diff
(99.0 %id)
BI333362 cervical carcinoma cell line, cervix .a 2479 to 3224 1 to 746       748/793
(94 %)
18 diff
(97.8 %id)
DB150140 thymus .a 2493 to 3020 2 to 529   capped   528/528
(100 %)
0 diff
(100 %id)
DB208649 trachea .a 2515 to 3040 2 to 527   capped   526/526
(100 %)
2 diff
(99.7 %id)
CB152176 brain .a 2559 to 3074 1 to 516       516/516
(100 %)
1 diff
(99.9 %id)
AA206525   .a 2603 to 3140 1 to 541       541/543
(99 %)
8 diff
(98.6 %id)
BU165187 eye, retinoblastoma .a 2616 to 3496 1 to 889       889/891
(99 %)
14 diff
(98.5 %id)
CN344618 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 2618 to 3356 12 to 751       740/751
(98 %)
7 diff
(99.1 %id)
BQ212585 embryonal carcinoma, cell line, testis .a 2632 to 3317 1 to 697       695/944
(73 %)
25 diff
(97.4 %id)
DA815407   .a 2677 to 3246 2 to 572   capped   571/571
(100 %)
1 diff
(99.9 %id)
DA783497 brain .a 2678 to 3163 2 to 487   capped   486/488
(99 %)
1 diff
(99.8 %id)
BX281151 eye, retinoblastoma .a 2743 to 3219 1 to 477       477/477
(100 %)
0 diff
(100 %id)
BM449456 eye, retinoblastoma .a 2743 to 3708 1 to 968       968/1007
(96 %)
14 diff
(98.7 %id)
CX783954 human embryonic stem cells .a 2785 to 3488 1 to 703       703/703
(100 %)
1 diff
(99.9 %id)
BI091492 cervix .a 2804 to 3560 1 to 753       755/753
(100 %)
6 diff
(99.3 %id)
BF813797 colon_ins .a 2808 to 3417 639 to 35     Submitted on the opposite strand 605/641
(94 %)
12 diff
(98.2 %id)
DA719608   .a 2846 to 3415 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
AW368940 head_neck .a 2884 to 3175 1 to 292       292/299
(97 %)
2 diff
(99.4 %id)
BG504940 embryonal carcinoma, testis .a 2891 to 3304 1 to 414       414/724
(57 %)
1 diff
(99.9 %id)
BG939131 Bone, Hip .a 2897 to 3543 1 to 647       647/647
(100 %)
3 diff
(99.6 %id)
BG779146 adenocarcinoma, Prostate .a 3027 to 3717 1 to 691       691/701
(98 %)
11 diff
(98.5 %id)
CN420739 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 3066 to 3852 1 to 787       787/787
(100 %)
0 diff
(100 %id)
BE884522 leiomyosarcoma, uterus .a 3086 to 3680 1 to 604       604/855
(70 %)
17 diff
(98.1 %id)
AU124375   .a 3097 to 3832 2 to 740   capped   739/788
(93 %)
7 diff
(99.2 %id)
DA647585   .a 3142 to 3953 2 to 812   capped   811/812
(99 %)
2 diff
(99.8 %id)
DA552828   .a 3146 to 3710 2 to 567   capped   566/566
(100 %)
1 diff
(99.9 %id)
CR997188 T-Lymphocytes .a 3152 to 4011 1 to 862       862/862
(100 %)
2 diff
(99.8 %id)
CX752748 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 3166 to 3854 1 to 689     Submitted on the opposite strand 689/689
(100 %)
0 diff
(100 %id)
CD557114 testis .a 3219 to 3853 45 to 690       646/992
(65 %)
47 diff
(95.3 %id)
FN158735 breast carcinoma .a 3236 to 3332 98 to 1     Submitted on the opposite strand 98/98
(100 %)
2 diff
(98.0 %id)
BQ427558 leiomyosarcoma, uterus .a 3279 to 4145 1 to 867       867/867
(100 %)
4 diff
(99.6 %id)
BF335852 colon .a 3426 to 3738 314 to 1       312/314
(99 %)
8 diff
(97.5 %id)
BF214821 bone marrow, from acute myelogenous leukemia .a 3470 to 4145 1 to 682       682/821
(83 %)
34 diff
(95.9 %id)
CN420738 embryonic stem cells, DMSO-treated H9 cellline .a 3477 to 3951 1 to 475       475/475
(100 %)
3 diff
(99.4 %id)
BE779501 eye, retinoblastoma .a 3484 to 4172 1 to 683       683/932
(73 %)
18 diff
(98.1 %id)
DW431173 Liver .a 3557 to 3815 12 to 270       259/270
(95 %)
6 diff
(97.8 %id)
BM542233 melanotic melanoma, skin .a 3570 to 4486 13 to 941       929/1051
(88 %)
24 diff
(97.8 %id)
BE169159 head_neck .a 3591 to 3800 13 to 227       216/267
(80 %)
17 diff
(93.7 %id)
BC008700 Muscle, rhabdomyosarcoma .a 3679 to 5381 1 to 1703   tiling clone, available from MGC, AAA   1703/1703
(100 %)
0 diff
(100 %id)
BE299984 muscle, rhabdomyosarcoma .a 3698 to 4454 1 to 744   available from MGC,   744/870
(85 %)
15 diff
(98.3 %id)
CN420740 embryonic stem cells, cell lines H1, H7, andH9 .a 3751 to 4306 1 to 556       556/557
(99 %)
0 diff
(100 %id)
CK430859 eye, lacrimal gland .a 3807 to 4420 1 to 614       614/614
(100 %)
0 diff
(100 %id)
BI258526 cervical carcinoma cell line, cervix .a 3821 to 4721 1 to 897       897/951
(94 %)
21 diff
(97.8 %id)
CR992672 T-Lymphocytes .a 3902 to 4840 1 to 938       938/938
(100 %)
4 diff
(99.6 %id)
CN420737 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 3904 to 4467 1 to 564       564/564
(100 %)
2 diff
(99.7 %id)
CB119927 Liver .a 3920 to 4343 1 to 424       424/424
(100 %)
0 diff
(100 %id)
EL950826 eyeball .a 3975 to 4541 1 to 567       567/567
(100 %)
4 diff
(99.3 %id)
BG288142 bladder, transitional cell papilloma, cell line .a 3980 to 4717 1 to 738       738/738
(100 %)
8 diff
(99.0 %id)
BG677492 skin, squamous cell carcinoma .a 3986 to 4880 1 to 893       893/895
(99 %)
17 diff
(98.2 %id)
BG109079 Bone, osteosarcoma, cell line .a 4025 to 4833 1 to 812       812/887
(91 %)
29 diff
(96.8 %id)
EH334288   .a 4034 to 4092 1 to 59       59/59
(100 %)
0 diff
(100 %id)
BI754892 brain .a 4067 to 4861 1 to 793       793/793
(100 %)
7 diff
(99.2 %id)
TI_57218444   .a 4067 to 4861 31 to 823       793/823
(96 %)
7 diff
(99.2 %id)
ES315832 melanoma cell line .a 4074 to 4471 494 to 92     Submitted on the opposite strand 401/494
(81 %)
8 diff
(98.4 %id)
BF208933 bladder, carcinoma, cell line .a 4127 to 4545 1 to 419       419/420
(99 %)
5 diff
(98.9 %id)
BF209165 bone marrow, from chronic myelogenous leukemia .a 4153 to 4805 1 to 649       649/649
(100 %)
33 diff
(95.0 %id)
BG028145 Bone, osteosarcoma, cell line .a 4179 to 4654 1 to 479       479/922
(51 %)
9 diff
(99.1 %id)
BG739873 skin .a 4183 to 4990 1 to 793       793/794
(99 %)
20 diff
(97.5 %id)
BF240526 bone marrow, from acute myelogenous leukemia .a 4204 to 4829 73 to 718       571/720
(79 %)
12 diff
(98.4 %id)
N53299 multiple sclerosis lesions .a 4205 to 4633 53 to 488       436/488
(89 %)
13 diff
(97.4 %id)
BQ224760 embryonal carcinoma, cell line, testis .a 4255 to 4727 1 to 477       477/1065
(44 %)
18 diff
(98.4 %id)
BE813732 breast_normal .a 4265 to 4603 11 to 346       338/346
(97 %)
13 diff
(96.3 %id)
BG485553 lung .a 4269 to 5081 1 to 821       821/852
(96 %)
37 diff
(95.7 %id)
BF968999 adrenal cortex carcinoma, cell line, adrenal gland .a 4315 to 5131 1 to 815       815/890
(91 %)
27 diff
(97.0 %id)
CN420736 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 4333 to 4936 1 to 604       604/604
(100 %)
0 diff
(100 %id)
BF217268 brain, glioblastoma .a 4333 to 4983 1 to 641       641/880
(72 %)
21 diff
(97.7 %id)
BG874971 breast .a 4359 to 4600 243 to 1       243/421
(57 %)
6 diff
(98.6 %id)
CD511937 Pooled-Skin .a 4359 to 5008 1 to 654       654/790
(82 %)
7 diff
(99.2 %id)
CA943334 Pancreas, Purified pancreatic islet .a 4383 to 4811 32 to 460       429/460
(93 %)
6 diff
(98.7 %id)
BF696658 brain, primitive neuroectoderm .a 4386 to 5138 1 to 736       736/837
(87 %)
39 diff
(95.4 %id)
BG496895 lung, mucoepidermoid carcinoma .a 4413 to 5140 1 to 723       723/724
(99 %)
11 diff
(98.5 %id)
W68807 heart .a 4415 to 4904 1 to 492   fully sequenced,   492/492
(100 %)
2 diff
(99.6 %id)
BU627107 Bone, Enchondroma cell line .a 4440 to 5135 714 to 19   AAA Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) 696/696
(100 %)
0 diff
(100 %id)
CA420042 Bone, Human Chondrosarcoma Cell Line .a 4508 to 5268 775 to 19   AAA   757/757
(100 %)
5 diff
(99.4 %id)
DB516195 testis .a 4543 to 5268 1 to 720     Submitted on the opposite strand 720/720
(100 %)
25 diff
(96.6 %id)
CB410461 maxilla, pooled .a 4549 to 5059 1 to 511   fully sequenced,   511/511
(100 %)
0 diff
(100 %id)
CN265359 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 4555 to 4873 1 to 318       318/318
(100 %)
8 diff
(97.5 %id)
AI114476 Liver .a 4579 to 5241 1 to 665   AAA   665/665
(100 %)
8 diff
(98.8 %id)
CB270202 adipose .a 4586 to 5131 1 to 547       547/548
(99 %)
3 diff
(99.5 %id)
CB853773 lung, Primary Lung Epithelial Cells .a 4592 to 4871 311 to 32       280/319
(87 %)
0 diff
(100 %id)
AW593619 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 4623 to 5270 649 to 1       649/666
(97 %)
9 diff
(98.7 %id)
TI_149282205   .a 4643 to 5238 727 to 132   AAA   596/1189
(50 %)
38 diff
(96.9 %id)
AI690203 carcinoid, lung .a 4670 to 5199 1 to 530     Submitted on the opposite strand 530/530
(100 %)
1 diff
(99.9 %id)
AI681503 carcinoid, lung .a 4670 to 5203 1 to 534     Submitted on the opposite strand 534/534
(100 %)
0 diff
(100 %id)
AU152474   .a 4692 to 5238 548 to 1       548/550
(99 %)
12 diff
(97.9 %id)
BY996607   .a 4701 to 5268 622 to 55   AAA Submitted on the opposite strand 568/568
(100 %)
2 diff
(99.7 %id)
DB368325   .a 4710 to 5238 528 to 1       528/528
(100 %)
24 diff
(95.5 %id)
AU151196   .a 4720 to 5268 543 to 1       543/543
(100 %)
10 diff
(98.2 %id)
CA310046 Bone, Enchondroma cell line .a 4721 to 5268 566 to 19   AAA   548/548
(100 %)
1 diff
(99.9 %id)
AI656261 pooled germ cell tumors .a 4759 to 5270 512 to 1       512/516
(99 %)
2 diff
(99.7 %id)
BQ023248 placenta .a 4774 to 5238 483 to 19   AAA   465/465
(100 %)
0 diff
(100 %id)
AI952719 pooled germ cell tumors .a 4783 to 5270 488 to 1       488/488
(100 %)
0 diff
(100 %id)
N48153 multiple sclerosis lesions .a 4801 to 5268 472 to 1       472/483
(97 %)
13 diff
(97.4 %id)
DB511249 testis .a 4802 to 5239 1 to 439     Submitted on the opposite strand 439/444
(98 %)
7 diff
(98.5 %id)
DB526837 testis .a 4814 to 5268 1 to 455     Submitted on the opposite strand 455/455
(100 %)
2 diff
(99.6 %id)
AI269483 pooled .a 4817 to 5271 455 to 1       455/455
(100 %)
0 diff
(100 %id)
AW665558 pooled .a 4822 to 5268 447 to 1       447/447
(100 %)
4 diff
(99.2 %id)
FN103941 breast carcinoma .a 4834 to 4929 95 to 1     Submitted on the opposite strand 95/96
(98 %)
1 diff
(99.0 %id)
BE535763 cervix .a 4838 to 5264 1 to 420       420/420
(100 %)
7 diff
(98.4 %id)
BF594277 colon, colon tumor, RER+ .a 4850 to 5238 399 to 11   AAA   389/389
(100 %)
3 diff
(99.3 %id)
BF513896   .a 4858 to 5268 428 to 18   AAA   411/411
(100 %)
2 diff
(99.6 %id)
BI335216 cervical carcinoma cell line, cervix .a 4859 to 5269 1 to 409       409/428
(95 %)
4 diff
(99.1 %id)
AW511789 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 4866 to 5271 406 to 1       406/406
(100 %)
0 diff
(100 %id)
W68609 heart .a 4874 to 5240 370 to 1   fully sequenced,   370/370
(100 %)
1 diff
(99.8 %id)
DB513710 testis .a 4880 to 5268 1 to 392     Submitted on the opposite strand 392/392
(100 %)
10 diff
(97.5 %id)
AA742226 germinal center B cell .a 4900 to 5239 365 to 26       340/365
(93 %)
0 diff
(100 %id)
BE774705 uterus .a 4918 to 5111 195 to 1       195/205
(95 %)
7 diff
(96.6 %id)
AW271391 Kidney .a 4921 to 5268 348 to 1       348/348
(100 %)
2 diff
(99.5 %id)
BE774834 uterus .a 4941 to 5124 183 to 2       182/194
(93 %)
0 diff
(100 %id)
AW795604 uterus .a 4950 to 5123 11 to 185       175/185
(94 %)
6 diff
(96.8 %id)
D29578   .a 4952 to 5270 1 to 321       321/321
(100 %)
3 diff
(99.1 %id)
BQ024601 placenta .a 4956 to 5268 331 to 19   AAA   313/313
(100 %)
1 diff
(99.7 %id)
CN344616 embryonic stem cells, DMSO-treated H9 cellline .a 4963 to 5235 273 to 1     Submitted on the opposite strand 273/273
(100 %)
0 diff
(100 %id)
AI934240 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 5020 to 5238 236 to 13   AAA   224/224
(100 %)
9 diff
(96.0 %id)
CB410460 maxilla, pooled .a 5029 to 5268 287 to 48   fully sequenced, AAA   240/240
(100 %)
1 diff
(99.6 %id)
BY999802   .a 5117 to 5271 1 to 155     Submitted on the opposite strand 155/155
(100 %)
0 diff
(100 %id)
AW051055 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 5124 to 5271 151 to 4       148/151
(98 %)
0 diff
(100 %id)
BX647634 human skeletal muscle .b 1 to 5252 1 to 5252 exact tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) 5252/5252
(100 %)
4 diff
(100.0 %id)
DB237553 trachea .b 1872 to 2440 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
AL832813 lymph node .b 3699 to 5222 1 to 1524   available from DKFZ,   1524/1529
(99 %)
2 diff
(99.9 %id)
AA129386 lung, lung carcinoma .b 4223 to 4780 1 to 558   fully sequenced,   558/558
(100 %)
14 diff
(97.5 %id)
BG534279 lung .b 4514 to 5206 1 to 699       699/702
(99 %)
12 diff
(98.3 %id)
BG939132 Bone, Hip .b 4564 to 5175 619 to 8       612/619
(98 %)
0 diff
(100 %id)
AA133292 lung, lung carcinoma .b 4583 to 4886 1 to 304   fully sequenced, Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) 304/304
(100 %)
0 diff
(100 %id)
AA129701 lung, lung carcinoma .b 4583 to 5231 1 to 649       649/649
(100 %)
7 diff
(99.0 %id)
BQ016062 lung, Metastatic Chondrosarcoma .b 4629 to 5220 607 to 16   AAA   592/592
(100 %)
5 diff
(99.2 %id)
BU754234 placenta .b 4642 to 5220 594 to 16   AAA   579/579
(100 %)
3 diff
(99.5 %id)
BF055234 pooled .b 4663 to 5217 555 to 1       555/555
(100 %)
1 diff
(99.9 %id)
AI634562 carcinoid, lung .b 4703 to 5222 521 to 2       520/521
(99 %)
0 diff
(100 %id)
CN420734 embryonic stem cells, cell lines H1, H7, andH9 .b 4728 to 5256 573 to 45   AAA Submitted on the opposite strand 529/531
(99 %)
1 diff
(99.9 %id)
BQ027421 mixed .b 4742 to 5217 495 to 19   AAA   477/477
(100 %)
2 diff
(99.6 %id)
AA129323 lung, lung carcinoma .b 4750 to 5220 473 to 1   fully sequenced,   473/473
(100 %)
4 diff
(99.2 %id)
R43961 whole brain .b 4754 to 5220 488 to 12   AAA   477/479
(99 %)
25 diff
(94.8 %id)
BG059812 brain, glioblastoma without EGFR amplification .b 4766 to 5219 454 to 1       454/454
(100 %)
1 diff
(99.8 %id)
D29021   .b 4786 to 5217 1 to 429       429/429
(100 %)
8 diff
(98.2 %id)
BQ025803 placenta .b 4791 to 5220 445 to 16   AAA   430/430
(100 %)
1 diff
(99.8 %id)
AI239764 pooled .b 4803 to 5220 418 to 1       418/418
(100 %)
0 diff
(100 %id)
AI678885 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .b 4803 to 5220 418 to 1       418/418
(100 %)
1 diff
(99.8 %id)
AI873730 serous papillary carcinoma, high grade, 2pooled tumors, uterus .b 4810 to 5220 411 to 1       411/412
(99 %)
4 diff
(99.1 %id)
AI538894 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .b 4824 to 5222 400 to 2       399/400
(99 %)
0 diff
(100 %id)
AA904475 pooled .b 4825 to 5220 396 to 1       396/396
(100 %)
0 diff
(100 %id)
AA653518   .b 4826 to 5219 394 to 1       394/394
(100 %)
0 diff
(100 %id)
AI287295 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 4836 to 5226 391 to 1       391/391
(100 %)
0 diff
(100 %id)
AA973355 carcinoid, lung .b 4851 to 5219 369 to 1       369/369
(100 %)
2 diff
(99.5 %id)
AA129745 lung, lung carcinoma .b 4856 to 5238 398 to 21   fully sequenced, AAA Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) 378/378
(100 %)
0 diff
(100 %id)
AI866872 adenocarcinoma, Pancreas .b 4858 to 5220 363 to 1       363/363
(100 %)
0 diff
(100 %id)
AA757303 pooled .b 4876 to 5216 341 to 1       341/341
(100 %)
0 diff
(100 %id)
AI186074 lung .b 4879 to 5221 343 to 1       343/343
(100 %)
1 diff
(99.8 %id)
AA737777 pooled germ cell tumors .b 4916 to 5226 311 to 1       311/311
(100 %)
0 diff
(100 %id)
AI825401 pooled germ cell tumors .b 4918 to 5222 308 to 3       306/308
(99 %)
0 diff
(100 %id)
CB069595 Pancreas, Purified pancreatic islet .b 5013 to 5222 218 to 9       210/218
(96 %)
0 diff
(100 %id)
DR980001 placenta .b 5026 to 5217 1 to 191   AAA Submitted on the opposite strand 191/191
(100 %)
3 diff
(98.5 %id)
AA587412 breast .b 5054 to 5222 175 to 7       169/175
(96 %)
0 diff
(100 %id)
DN920557   .b 5072 to 5218 149 to 3       147/149
(98 %)
0 diff
(100 %id)
AK302396 testis .c 1 to 1960 2 to 1961 exact tiling clone,   1961/1961
(100 %)
1 diff
(100.0 %id)
DC399967 testis .c 1 to 548 2 to 550       550/550
(100 %)
1 diff
(99.9 %id)
DC400280 testis .c 1 to 536 2 to 538       538/538
(100 %)
2 diff
(99.7 %id)
DC400065 testis .c 1128 to 1702 1 to 576       576/576
(100 %)
2 diff
(99.7 %id)
AU117488 whole embryo, mainly head .d 1 to 818 2 to 819   tiling clone, capped   818/818
(100 %)
4 diff
(99.6 %id)
DB355312 whole embryo, mainly head .d 912 to 1438 527 to 1   tiling clone,   527/566
(93 %)
8 diff
(98.6 %id)
BQ948277 epidermoid carcinoma, cell line, lung .e 1 to 865 1 to 875   tiling clone,   875/875
(100 %)
15 diff
(98.3 %id)
BF970088 adrenal cortex carcinoma, cell line, adrenal gland .e 399 to 1212 1 to 815   tiling clone,   815/1112
(73 %)
43 diff
(96.2 %id)
DB062015 testis .f 1 to 560 2 to 562   tiling clone, capped   561/561
(100 %)
1 diff
(99.9 %id)
BI836206 pooled pancreas and spleen .f 429 to 1015 1 to 586   tiling clone,   584/586
(99 %)
5 diff
(99.2 %id)
TI_57164916   .f 431 to 1015 35 to 618       583/618
(94 %)
8 diff
(98.8 %id)
AW672826 cervix .f 722 to 1146 1 to 426   tiling clone,   426/426
(100 %)
2 diff
(99.6 %id)
CR606216 Placenta Cot 25-normalized .g 1 to 1481 1 to 1481 exact tiling clone,   1481/1481
(100 %)
0 diff
(100 %id)
BI559779 testis .g 2 to 646 1 to 647       647/647
(100 %)
16 diff
(97.6 %id)
TI_44348039   .g 7 to 646 95 to 736       642/736
(87 %)
15 diff
(98.0 %id)
AA355431   .g 10 to 154 1 to 145       145/145
(100 %)
3 diff
(98.0 %id)
DA333972 hippocampus .g 24 to 600 2 to 579   capped   578/578
(100 %)
1 diff
(99.9 %id)
BX340453 Placenta Cot 25-normalized .g 30 to 532 22 to 512   fully sequenced,   491/512
(95 %)
8 diff
(98.5 %id)
BF027488 melanotic melanoma, skin .g 49 to 758 1 to 701   available from MGC,   701/701
(100 %)
15 diff
(97.9 %id)
BG478084 melanotic melanoma, skin .g 50 to 694 1 to 646       646/646
(100 %)
8 diff
(98.8 %id)
BC009822 Skin, melanotic melanoma. .g 51 to 1532 1 to 1482 exact tiling clone, available from MGC, AAA   1482/1482
(100 %)
0 diff
(100 %id)
BE384944 melanotic melanoma, skin .g 70 to 766 1 to 717       717/721
(99 %)
40 diff
(94.5 %id)
AU119509 whole embryo, mainly head .g 201 to 984 2 to 785   fully sequenced, capped   784/784
(100 %)
4 diff
(99.5 %id)
BF695968 brain, primitive neuroectoderm .g 222 to 897 1 to 674       674/887
(75 %)
47 diff
(94.8 %id)
AK026236 human small intestine .g 229 to 1537 1 to 1309   available from FLJ, AAA   1309/1309
(100 %)
2 diff
(99.9 %id)
CV028199 mixed .g 238 to 806 1 to 569       569/613
(92 %)
1 diff
(99.9 %id)
BX340452 Placenta Cot 25-normalized .g 502 to 1481 981 to 1   fully sequenced,   981/981
(100 %)
13 diff
(98.7 %id)
AW390256 stomach .g 732 to 1394 686 to 26       661/689
(95 %)
0 diff
(100 %id)
AI733785 lung, lung carcinoma .g 929 to 1285 9 to 365       357/365
(97 %)
6 diff
(98.4 %id)
DB357932 whole embryo, mainly head .g 956 to 1532 573 to 1   fully sequenced,   573/573
(100 %)
8 diff
(98.7 %id)
AA135971 lung, lung carcinoma .g 966 to 1294 1 to 331       331/331
(100 %)
2 diff
(99.4 %id)
AW969463   .g 972 to 1393 1 to 422       422/422
(100 %)
0 diff
(100 %id)
AA502906 colon .g 1066 to 1321 256 to 1       256/256
(100 %)
0 diff
(100 %id)
AA135836 lung, lung carcinoma .g 1335 to 1537 208 to 6       203/208
(97 %)
0 diff
(100 %id)
AA479774 ovarian tumor, ovary .h 1 to 459 1 to 457   tiling clone,   457/457
(100 %)
2 diff
(99.6 %id)
AA477348 ovarian tumor, ovary .h 614 to 1040 452 to 26   tiling clone, AAA   427/427
(100 %)
0 diff
(100 %id)
BE782858 eye, retinoblastoma .i 1 to 707 4 to 704 exact tiling clone,   704/836
(84 %)
10 diff
(98.9 %id)
DB446163 testis .j 1 to 356 1 to 356 P108Q E109R E110K E111R I112L ... tiling clone,   356/419
(84 %)
7 diff
(98.4 %id)
BU663147 blood .k 1 to 571 570 to 1   tiling clone, Submitted on the opposite strand 570/570
(100 %)
2 diff
(99.7 %id)
AV653935 corresponding non cancerous liver tissue .k 189 to 529 1 to 341   tiling clone, Submitted on the opposite strand 341/350
(97 %)
1 diff
(99.8 %id)
AV718400 corresponding non cancerous liver tissue .k 1255 to 1733 479 to 1   tiling clone, Submitted on the opposite strand 479/479
(100 %)
0 diff
(100 %id)
BX482536   .l 1 to 634 634 to 1 L7W D8I L9F S10P W11G ... tiling clone, Submitted on the opposite strand 634/634
(100 %)
3 diff
(99.6 %id)
BX644876   .l 234 to 634 401 to 1   tiling clone, Submitted on the opposite strand 401/401
(100 %)
1 diff
(99.8 %id)
DA544588   .m 1 to 544 2 to 545 I39F tiling clone, capped   544/544
(100 %)
1 diff
(99.9 %id)
BE076449 breast .n -11 to 343 4 to 358 A2R A3R A4R G5D tiling clone,   355/361
(98 %)
8 diff
(97.8 %id)
BE697094 colon .o 1 to 354 25 to 377 P6T L7S S8E Q9P T10N ... tiling clone,   353/379
(93 %)
9 diff
(97.7 %id)
BF229982 colon .o 1 to 349 353 to 7 Q9P F56C tiling clone,   347/353
(98 %)
1 diff
(99.8 %id)
AA256085 germinal center B cell .p-u 1 to 428 1 to 428   tiling clone,   428/428
(100 %)
1 diff
(99.8 %id)
BU617916 Bone, Subchondral Bone .p-u 213 to 880 686 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) 668/668
(100 %)
0 diff
(100 %id)
R50025 breast .p-u 311 to 596 1 to 295   fully sequenced,   295/295
(100 %)
6 diff
(98.0 %id)
AA365022 pineal body .p-u 356 to 591 1 to 236       236/237
(99 %)
1 diff
(99.6 %id)
DW413308 Liver .p-u 400 to 703 17 to 320       304/320
(95 %)
7 diff
(97.9 %id)
DW410640 Liver .p-u 519 to 835 17 to 333       317/333
(95 %)
6 diff
(98.2 %id)
R50364 breast .p-u 566 to 880 325 to 1   fully sequenced,   325/325
(100 %)
8 diff
(97.6 %id)
BM041279 Kidney, Wilms' tumor, cell line .p-u 685 to 1486 1 to 811   tiling clone, fully sequenced,   811/811
(100 %)
62 diff
(92.4 %id)
BM041409 Kidney, Wilms' tumor, cell line .p-u 1456 to 2021 594 to 17 E20* tiling clone, fully sequenced,   578/594
(97 %)
20 diff
(96.7 %id)
DW432156 Liver .q-u 1 to 257 10 to 266 V2R C3G tiling clone,   257/266
(96 %)
5 diff
(98.2 %id)
BM822907 stomach .q-u 161 to 523 1 to 363   tiling clone,   363/363
(100 %)
0 diff
(100 %id)
BE550283 pooled germ cell tumors .q-u 187 to 546 359 to 1       359/359
(100 %)
2 diff
(99.5 %id)
BE672040 pooled germ cell tumors .q-u 187 to 546 359 to 1       359/359
(100 %)
1 diff
(99.8 %id)
BE825942 lung_normal .q-u 403 to 755 1 to 348   tiling clone,   348/351
(99 %)
16 diff
(95.5 %id)
BQ377965 uterus .q-u 545 to 847 306 to 4   tiling clone,   303/323
(93 %)
0 diff
(100 %id)
BQ377982 uterus .q-u 545 to 847 306 to 4       303/323
(93 %)
0 diff
(100 %id)
BG618748 Liver .r-u 1 to 710 1 to 712 exact tiling clone,   712/712
(100 %)
10 diff
(98.6 %id)
BX501115 Liver .s-u 1 to 689 1 to 687 P8Q G9A C10A S11V I12L ... tiling clone,   687/687
(100 %)
5 diff
(99.3 %id)
BX955482   .t-u 1 to 471 1 to 471 exact tiling clone,   471/471
(100 %)
0 diff
(100 %id)
AA359105 lung .t-u 432 to 635 1 to 204   tiling clone,   204/204
(100 %)
0 diff
(100 %id)
BG992025 head_neck .u 1 to 611 1 to 607 H4A A5C P6T R8T G9R ... tiling clone,   607/607
(100 %)
48 diff
(92.1 %id)
AA626484 lung, lung carcinoma .u 213 to 629 1 to 417   tiling clone,   417/417
(100 %)
0 diff
(100 %id)
DA264230 caudate nucleus .va 1 to 558 2 to 560 W66V I67D V68C Q69A P70A ... tiling clone, capped   559/559
(100 %)
1 diff
(99.9 %id)
BF790392 muscle (skeletal) .va 87 to 627 1 to 537 F27L E28S Y29M G30E M31C ... tiling clone,   537/538
(99 %)
6 diff
(98.9 %id)
AI148447   .va 143 to 614 486 to 15 G30V tiling clone, AAA   472/472
(100 %)
2 diff
(99.6 %id)
CN420741 embryonic stem cells, cell lines H1, H7, andH9 .vb 1 to 599 1 to 599 exact tiling clone,   599/599
(100 %)
0 diff
(100 %id)
DW440131 Liver .vc-u 182 to 413 8 to 239   tiling clone,   232/239
(97 %)
15 diff
(93.8 %id)
BX641486   .vd 1 to 558 1 to 558 exact tiling clone,   558/558
(100 %)
1 diff
(99.9 %id)
DW426947 Liver .ve-u 1 to 264 17 to 280 D30H G38* tiling clone,   264/280
(94 %)
6 diff
(97.9 %id)
BE698573 uterus_tumor .vf-u 1 to 258 266 to 6 V7G T8Y S9I F10H L11S ... tiling clone,   261/280
(93 %)
0 diff
(100 %id)
CB851640 lung, Primary Lung Cystic Fibrosis EpithelialCells Gene NUP160, variant not shown       AAA This clone was ignored    
D83781   Gene NUP160, variant not shown       available from KIAA, This clone was ignored    
BX503655.
matches multiple genes
  Gene NUP160, variant not shown         This clone was ignored, also hits gene tersnawby    
BX503655.
matches multiple genes
  Gene tersnawby, variant not shown         This clone was ignored, also hits gene tersnawby    
BX503656.
matches multiple genes
  Gene NUP160, variant not shown         This clone was ignored, also hits gene tersnawby    
BX503656.
matches multiple genes
  Gene tersnawby, variant not shown         This clone was ignored, also hits gene tersnawby    
BJ990814 hepatoblastoma Gene NUP160, variant not shown         This clone was ignored    
BJ990815 hepatoblastoma Gene NUP160, variant not shown         This clone was ignored    
BF375189 stomach Gene NUP160, variant not shown              
DB278776 uterus Gene NUP160, variant not shown       capped      
CV362919 uterus Gene NUP160, variant not shown              
DA095971 cerebellum Gene NUP160, variant not shown       capped Suspected internal deletion, this clone was ignored    
DB131589 thymus Gene NUP160, variant not shown       capped      
DB344648 thymus Gene NUP160, variant not shown              
TI_149314333   Gene NUP160, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p-u, .q-u, .r-u, .s-u, .t-u, .u, .va, .vb, .vc-u, .vd, .ve-u, .vf-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI